Skip to content

Clinical trials

Withdrawn Lung Neoplasms trials in China

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lung Neoplasms Status: Withdrawn Country / region: China Clear all

17 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20151
20162
20174
20182
20202
20212
20231
20242
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Withdrawn17

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Sun Yat-sen University4
China Medical University, China1
Chongqing Precision Biotech Co., Ltd1
First Affiliated Hospital Xi'an Jiaotong University1
Fuda Cancer Hospital, Guangzhou1
Guangdong Provincial People's Hospital1
Henan Cancer Hospital1
Hutchison Medipharma Limited1
Ruijin Hospital1
Shanghai Pulmonary Hospital, Shanghai, China1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lung Neoplasms17
Breast Neoplasms3
Colorectal Neoplasms2
Pancreatic Neoplasms2
Stomach Neoplasms2
Carcinoma, Non-Small-Cell Lung1
Esophageal Neoplasms1
Glioma1
Liver Neoplasms1
Multiple Pulmonary Nodules1

Trials

Showing 1 to 17 of 17. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.